4//SEC Filing
Breedlove Robert Charles 4
Accession 0000950170-25-096917
CIK 0001783183other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:05 PM ET
Size
5.9 KB
Accession
0000950170-25-096917
Insider Transaction Report
Form 4
Breedlove Robert Charles
Principal Accounting Officer
Transactions
- Sale
Common Stock
2025-07-16$8.36/sh−1,692$14,152→ 48,392 total
Holdings
- 5,108.4(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in mutliple transactions at prices $8.364 and $8.35. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0002066645
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 4:05 PM ET
- Size
- 5.9 KB